In France, on newly acquired land located 7 km from the existing site in Riom north of Clermont-Ferrand in Auvergne, construction have begun in January 2021 with a new, state-of-the-art facility dedicated to custom development and manufacturing of parenteral drug products.
This new state-of-the-art facility will allow for larger capacities to supply our customers with clinical batches for phase III clinical trials and small-scale for commercial. The handling of complex formulations will include a large range of APIs from biologics to highly potent compounds.
Operations will commence during Q1 of 2023.
|Line 1 – liquid & lyophilized form
|Line 2 – Fill & Finish
Vials, Prefilled Syringes and Cartridges
|Formulation||Up to 400 Litres tank|
|Batch Size||30k units of 2R – up to 45k||3.6k units per hour|
|Formats||Vials from 2 to 100R||Vials from 2 to 100R
PFS 1 to 10ml (option)
|API Categories||Full containment - From Cat 1 to Cat 4+|
|Special Features||Low temperature - Inert atmosphere - Viscous products - Aseptic formulation - Minimised losses|